BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
In 1989, H. Stewart Parker became CEO of Targeted Genetics, an Immunex Corp. spin-off in Seattle. which specialized…
In 1986, Dr. Marilyn Hughes Gaston while deputy branch chief of the Sickle Cell Disease Branch at the…
On Dec. 2, 1985, the first clinical tests were held at the University of Washington of erythropoietin (EPO),…
On Jul. 16, 1983, the National Cancer Institute launched the Community Clinical Oncology Program (CCOP) to provide a…
In 1983, the National Cancer Institute’s Division of Resources, Centers and Community Activities was renamed the Division of…
In 1983, the Community Clinical Oncology Program, an National Cancer Institute (NCI) resource that links community-based physicians with…
On Apr. 27, 1981, a new Biological Response Modifiers Program was established in the Division of Cancer Treatment…
On Nov. 9, 1978, the first human testing of a biological therapy was conducted (alpha-interferon). The Cancer Research…
In 1978, Ontario researchers led by Dr. Henry Barnett demonstrated that Aspirin can prevent strokes. Five hundred and…
In 1977, the National Cancer Institute (NCI) established the first electronic registry of cancer clinical trials (CLINPROT). This…
In 1977, the U.S. Food and Drug Administration (FDA) established the Bioresearch Monitoring Program (BiMo) to develop cross-center…
In 1976, the Ohio State University Cancer Center (OSUCCC) received National Cancer Institute (NCI) comprehensive center designation. The…
In 1973, the Norris Comprehensive Cancer Center, now the University of Southern California Kenneth Norris Jr. Cancer Center…
In 1973, the Norris Cancer Center was designated a National Cancer Institute (NCI) Comprehensive Cancer Center, one of…
In 1970, Cisplatin, a platinum-containing anticancer compound with unique biologic effects, entered clinical trials. On Dec. 19, 1978,…
In 1970, Dr. Calvin Stiller conducted one of the first clinical trials studying the effectiveness of the immunosuppressive…
On Sept. 21, 1960, FDA officials announced the last remaining major source of the discredited Hoxsey cancer treatment…
In 1960, the U.S. Public Health Service (USPHS) TB control and clinical research program was transferred to the…
In 1955, The National Cancer Chemotherapy Program was initiated. It was administered and integrated by the Division of…
In 1955, the NCIï¾’s Cooperative Group Program for clinical research was established in 1955 and has grown to…
In 1955, Hydroxychloroquine (HCQ) was approved for medical use in the U.S. in 1955. Chloroquine was discovered in…
In 1953, Dr. Heinz E. Lehmann and Dr. G. Hanrahan of Montreal conducted the first clinical trial of…
In 1948, the National Cancer Institute’s grants program to medical, dental, and osteopathic schools was initiated for improvement…
In 1914, the first ‘mechanical lung’, developed by Charles Morgan Hammond, M.D., passed its first clinical test at…
On May 20, 1747, James Lind of the British Royal Navy started his famous scurvy clinical trial. In…